https://medicaex.com/businesswire/insights-on-the-robotic-surgery-for-cervical-cancer-global-market-to-2027-growing-prevalence-of-cervical-cancer-and-adoption-of-robotic-surgery-is-driving-growth-researchandmarkets-com-2/ 2022-11-18T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-cuU5aJ.jpeg https://medicaex.com/businesswire/interstate-health-systems-launches-with-oversold-pre-seed-investment-round-3/ 2022-11-18T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Interstate_Logo-GLduFL.jpeg https://medicaex.com/businesswire/global-invisible-orthodontics-market-research-report-to-2027-featuring-3m-align-technology-bernhard-foerster-and-db-orthodontics-among-others-researchandmarkets-com/ 2022-11-18T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-QU6Pdi.jpeg https://medicaex.com/businesswire/silicon-battery-market-global-report-2022-high-energy-density-compared-to-other-battery-chemistries-driving-growth-researchandmarkets-com/ 2022-11-18T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-RE2pic.jpeg https://medicaex.com/businesswire/worldwide-single-use-ophthalmic-surgical-devices-industry-to-2027-material-improvements-used-in-single-use-surgical-devices-is-driving-growth-researchandmarkets-com/ 2022-11-18T17:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-VL9fBq.jpeg https://medicaex.com/businesswire/insights-on-the-robotic-surgery-for-cervical-cancer-global-market-to-2027-growing-prevalence-of-cervical-cancer-and-adoption-of-robotic-surgery-is-driving-growth-researchandmarkets-com/ 2022-11-18T17:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-reFMs0.jpeg https://medicaex.com/businesswire/lysogene-provides-updates-and-topline-results-from-phase-2-3-aavance-gene-therapy-clinical-study/ 2022-11-18T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Lysogene_-_Logo-9qhs96.jpeg https://medicaex.com/businesswire/interstate-health-systems-launches-with-oversold-pre-seed-investment-round-2/ 2022-11-18T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Interstate_Logo-y4pCEj.jpeg https://medicaex.com/businesswire/interstate-health-systems-launches-with-oversold-pre-seed-investment-round/ 2022-11-18T17:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Interstate_Logo-mUkKSS.jpeg https://medicaex.com/businesswire/home-healthcare-provider-cera-further-invests-in-its-technology-and-data-insights-to-reduce-the-cost-of-healthcare-by-over-10-fold-3/ 2022-11-18T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cera_Logo_PNG-amUpwL.jpeg https://medicaex.com/businesswire/north-america-human-leukocyte-antigen-testing-market-report-2022-rising-government-funding-for-organ-donation-presents-opportunities-researchandmarkets-com/ 2022-11-18T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-cSQclY.jpeg https://medicaex.com/businesswire/home-healthcare-provider-cera-further-invests-in-its-technology-and-data-insights-to-reduce-the-cost-of-healthcare-by-over-10-fold-2/ 2022-11-18T16:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cera_Logo_PNG-0dvtMs.jpeg https://medicaex.com/businesswire/home-healthcare-provider-cera-further-invests-in-its-technology-and-data-insights-to-reduce-the-cost-of-healthcare-by-over-10-fold/ 2022-11-18T16:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cera_Logo_PNG-Y1h4eR.jpeg https://medicaex.com/businesswire/worldwide-3d-bioprinting-industry-to-2027-players-include-aspect-biosystems-biolife4d-brinter-cellbricks-and-collplant-researchandmarkets-com-2/ 2022-11-18T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-FI5sPl.jpeg https://medicaex.com/businesswire/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board-2/ 2022-11-18T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/ArrePath_640x360_CAN_USE_THIS-zDkC3z.jpeg https://medicaex.com/businesswire/delbert-laboratories-are-proud-to-announce-the-acquisition-from-noventia-pharma-srl-of-the-european-marketing-authorisation-of-ceplene-0-5mg-0-5ml-2/ 2022-11-18T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Laboratoires_Delbert-6xsxxU.jpeg https://medicaex.com/businesswire/worldwide-3d-bioprinting-industry-to-2027-players-include-aspect-biosystems-biolife4d-brinter-cellbricks-and-collplant-researchandmarkets-com/ 2022-11-18T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-k17exY.jpeg https://medicaex.com/businesswire/condor-technologies-announces-proposal/ 2022-11-18T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Condor_Logo-rJSUii.jpeg https://medicaex.com/businesswire/arrepath-appoints-connor-coley-phd-and-paul-hergenrother-phd-to-scientific-advisory-board/ 2022-11-18T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/ArrePath_640x360_CAN_USE_THIS-qCS7ef.jpeg https://medicaex.com/businesswire/delbert-laboratories-are-proud-to-announce-the-acquisition-from-noventia-pharma-srl-of-the-european-marketing-authorisation-of-ceplene-0-5mg-0-5ml/ 2022-11-18T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Laboratoires_Delbert-za2GS7.jpeg https://medicaex.com/businesswire/global-cold-chain-logistics-market-for-pharmaceuticals-industry-to-grow-by-11-6-billion-during-2023-2027-researchandmarkets-com/ 2022-11-18T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-s4Pp5z.jpeg https://medicaex.com/businesswire/idex-corporation-completes-acquisition-of-muon-group/ 2022-11-18T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/IDEX_Tagline_Blue_Stacked_Square_28129-xpaLeT.jpeg https://medicaex.com/businesswire/revelation-biosciences-inc-announces-future-clinical-development-plans-based-on-recent-biomarker-analysis-and-significant-reduction-in-new-collagen-deposition-fibrosis-in-preclinical-model-2/ 2022-11-18T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/revelation-cFXFxY.jpeg https://medicaex.com/businesswire/schrodinger-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/ 2022-11-18T14:12:08+00:00 https://medicaex.com/businesswire/global-controlled-environment-ppe-market-report-2022-sustainable-product-innovation-and-reshoring-activities-presents-opportunities-researchandmarkets-com/ 2022-11-18T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-PW65dD.jpeg https://medicaex.com/businesswire/mirum-pharmaceuticals-to-participate-in-upcoming-investor-conferences/ 2022-11-18T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Mirum_Inline_FullColor_RGB-HfkoDI.jpeg https://medicaex.com/businesswire/schrodinger-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/ 2022-11-18T14:12:05+00:00 https://medicaex.com/businesswire/marinus-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-5635c4/ 2022-11-18T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/marinus-color-HxOSnj.jpeg https://medicaex.com/businesswire/revelation-biosciences-inc-announces-future-clinical-development-plans-based-on-recent-biomarker-analysis-and-significant-reduction-in-new-collagen-deposition-fibrosis-in-preclinical-model/ 2022-11-18T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/revelation-qLx1BR.jpeg https://medicaex.com/businesswire/hifibio-therapeutics-announces-clinical-trial-supply-agreement-to-evaluate-hfb200603-in-combination-with-tislelizumab-in-patients-with-dis-selected-advanced-solid-tumors-3/ 2022-11-18T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-RGB-300-3bSDr4.jpeg https://medicaex.com/businesswire/biocept-appoints-financial-executive-quyen-dao-haddock-to-its-board-of-directors-2/ 2022-11-18T13:12:15+00:00 https://medicaex.com/businesswire/kyowa-kirin-and-mei-pharma-announce-topline-data-from-the-phase-2-mirage-study-evaluating-zandelisib-in-patients-with-indolent-b-cell-non-hodgkins-lymphoma-in-japan-2/ 2022-11-18T13:12:15+00:00 https://medicaex.com/businesswire/twist-bioscience-reports-fiscal-fourth-quarter-and-full-year-fiscal-2022-financial-results-2/ 2022-11-18T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Twist_Bioscience_Logo-OXlLra.jpeg https://medicaex.com/businesswire/monrol-and-futurechem-announced-a-clinical-supply-partnership-4/ 2022-11-18T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Monrol-6XSBD1.jpeg https://medicaex.com/businesswire/viz-ai-announces-positive-new-data-from-large-aortic-dissection-ai-real-world-study-at-the-2022-veithsymposium/ 2022-11-18T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/HorizontalLogo_Whitebg-lg5K12.jpeg https://medicaex.com/businesswire/monrol-and-futurechem-announced-a-clinical-supply-partnership-3/ 2022-11-18T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Monrol-k4KCg8.jpeg https://medicaex.com/businesswire/monrol-and-futurechem-announced-a-clinical-supply-partnership-2/ 2022-11-18T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Monrol-T8G1qh.jpeg https://medicaex.com/businesswire/hifibio-therapeutics-announces-clinical-trial-supply-agreement-to-evaluate-hfb200603-in-combination-with-tislelizumab-in-patients-with-dis-selected-advanced-solid-tumors-2/ 2022-11-18T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-RGB-300-0m8vC4.jpeg https://medicaex.com/businesswire/monrol-and-futurechem-announced-a-clinical-supply-partnership/ 2022-11-18T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Monrol-SYUkEp.jpeg https://medicaex.com/businesswire/2022-technological-innovations-and-growth-opportunities-in-diagnostic-biochips-huge-demand-for-precision-medicine-and-low-cost-point-of-care-diagnostic-platforms-will-drive-growth-researchandmarket-2/ 2022-11-18T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-m3tyeh.jpeg https://medicaex.com/businesswire/twist-bioscience-reports-fiscal-fourth-quarter-and-full-year-fiscal-2022-financial-results/ 2022-11-18T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Twist_Bioscience_Logo-UEzEwv.jpeg https://medicaex.com/businesswire/rite-aid-announces-extension-of-early-tender-deadline-and-amendments-to-its-previously-announced-cash-tender-offer-and-consent-solicitation-for-its-7-500-senior-secured-notes-due-2025/ 2022-11-18T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/RAD-Logo-PMS-8teQRu.jpeg https://medicaex.com/businesswire/hifibio-therapeutics-announces-clinical-trial-supply-agreement-to-evaluate-hfb200603-in-combination-with-tislelizumab-in-patients-with-dis-selected-advanced-solid-tumors/ 2022-11-18T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-RGB-300-DZxCJQ.jpeg https://medicaex.com/businesswire/biocept-appoints-financial-executive-quyen-dao-haddock-to-its-board-of-directors/ 2022-11-18T13:12:06+00:00 https://medicaex.com/businesswire/kyowa-kirin-and-mei-pharma-announce-topline-data-from-the-phase-2-mirage-study-evaluating-zandelisib-in-patients-with-indolent-b-cell-non-hodgkins-lymphoma-in-japan/ 2022-11-18T13:12:06+00:00 https://medicaex.com/businesswire/2022-technological-innovations-and-growth-opportunities-in-diagnostic-biochips-huge-demand-for-precision-medicine-and-low-cost-point-of-care-diagnostic-platforms-will-drive-growth-researchandmarket/ 2022-11-18T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-EOqxBh.jpeg https://medicaex.com/businesswire/cancer-gene-therapy-market-report-2022-rising-rd-investments-and-demand-for-novel-cancer-therapeutics-driving-growth-researchandmarkets-com/ 2022-11-18T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-9bscLa.jpeg https://medicaex.com/businesswire/delphinus-medical-technologies-to-demonstrate-softvue-whole-breast-ultrasound-system-at-rsna-annual-meeting-3/ 2022-11-18T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/DELPHINUS_SoftVue-bYR75F.jpeg https://medicaex.com/businesswire/croivalve-reports-successful-first-in-human-implants-of-its-duo-tricuspid-coaptation-valve-system-2/ 2022-11-18T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Picture1-eHcpRB.jpeg https://medicaex.com/businesswire/orthofix-and-seaspine-announce-john-bostjancic-to-serve-as-cfo-for-combined-company-post-closing-2/ 2022-11-18T12:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Orthofix_Line_Logo-zDu6OE.jpeg https://medicaex.com/businesswire/delphinus-medical-technologies-to-demonstrate-softvue-whole-breast-ultrasound-system-at-rsna-annual-meeting-2/ 2022-11-18T12:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/DELPHINUS_SoftVue-772Hy9.jpeg https://medicaex.com/businesswire/delphinus-medical-technologies-to-demonstrate-softvue-whole-breast-ultrasound-system-at-rsna-annual-meeting/ 2022-11-18T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/DELPHINUS_SoftVue-1Ykde4.jpeg https://medicaex.com/businesswire/croivalve-reports-successful-first-in-human-implants-of-its-duo-tricuspid-coaptation-valve-system/ 2022-11-18T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Picture1-B2oHDx.jpeg https://medicaex.com/businesswire/orthofix-and-seaspine-announce-john-bostjancic-to-serve-as-cfo-for-combined-company-post-closing/ 2022-11-18T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Orthofix_Line_Logo-R6xaqQ.jpeg https://medicaex.com/businesswire/axonics-to-participate-in-the-piper-sandler-healthcare-conference-2/ 2022-11-18T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Axonics_Logo_-_Color-7DiFr2.jpeg https://medicaex.com/businesswire/axonics-to-participate-in-the-piper-sandler-healthcare-conference/ 2022-11-18T11:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Axonics_Logo_-_Color-euUqbC.jpeg https://medicaex.com/businesswire/the-worldwide-electrosurgery-industry-is-expected-to-reach-8-4-billion-by-2028-at-a-5-9-cagr-researchandmarkets-com/ 2022-11-18T10:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-h59mSy.jpeg https://medicaex.com/businesswire/oral-drug-delivery-global-market-report-2022-featuring-pfizer-astrazeneca-alpex-pharma-globela-lupin-adhexpharma-more-researchandmarkets-com/ 2022-11-18T10:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-24JWUN.jpeg https://medicaex.com/businesswire/lysogene-to-provide-updates-and-topline-results-from-phase-2-3-aavance-gene-therapy-clinical-study-and-host-webcast-on-wednesday-november-23-2022-2/ 2022-11-18T07:13:34+00:00 https://medicaex.com/wp-content/uploads/2022/11/Lysogene_-_Logo-nwgq5H.jpeg https://medicaex.com/businesswire/patrys-appoints-global-biotechnology-leader-as-chairman-in-preparation-for-first-clinical-trial-for-groundbreaking-cancer-therapy-2/ 2022-11-18T07:13:34+00:00 https://medicaex.com/wp-content/uploads/2022/11/Dr_Charmaine_Gittleson_Patrys_Chairman_of_the_Board_of_Directors-dkrCGg.jpeg https://medicaex.com/businesswire/lysogene-to-provide-updates-and-topline-results-from-phase-2-3-aavance-gene-therapy-clinical-study-and-host-webcast-on-wednesday-november-23-2022/ 2022-11-18T07:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Lysogene_-_Logo-stncQj.jpeg https://medicaex.com/businesswire/patrys-appoints-global-biotechnology-leader-as-chairman-in-preparation-for-first-clinical-trial-for-groundbreaking-cancer-therapy/ 2022-11-18T07:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Dr_Charmaine_Gittleson_Patrys_Chairman_of_the_Board_of_Directors-2zVP3t.jpeg https://medicaex.com/businesswire/geron-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3/ 2022-11-17T22:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Geron_Full_Logo_RGB-01-m1mP1A.jpeg https://medicaex.com/businesswire/carmell-therapeutics-gains-alignment-with-fda-on-a-path-forward-to-evaluate-the-use-of-its-lead-product-a-bone-healing-accelerant-in-foot-and-ankle-fusion-surgery-4/ 2022-11-17T22:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/CArmell_Logo-hZzKBK.jpeg https://medicaex.com/businesswire/bioohio-relaunches-as-ohio-life-sciences-ols-a-new-brand-and-reorganization-reflecting-the-dynamic-life-sciences-ecosystem-in-the-state-of-ohio-2/ 2022-11-17T22:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/OLS_Launch_For_Press-fAzAuT.jpeg https://medicaex.com/businesswire/geron-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/ 2022-11-17T22:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Geron_Full_Logo_RGB-01-C8ngPX.jpeg https://medicaex.com/businesswire/cue-health-announces-appointment-of-josh-ghaim-ph-d-and-sachin-jain-m-d-to-its-board-of-directors-3/ 2022-11-17T22:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cue_Logo-X8VGmI.jpeg https://medicaex.com/businesswire/mitre-and-miami-dade-college-to-collaborate-on-research-and-stem-talent-development/ 2022-11-17T22:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/https_commmitre-r7gOIt.jpeg https://medicaex.com/businesswire/bioohio-relaunches-as-ohio-life-sciences-ols-a-new-brand-and-reorganization-reflecting-the-dynamic-life-sciences-ecosystem-in-the-state-of-ohio/ 2022-11-17T22:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/OLS_Launch_For_Press-Fv3taM.jpeg https://medicaex.com/businesswire/cue-health-announces-appointment-of-josh-ghaim-ph-d-and-sachin-jain-m-d-to-its-board-of-directors-2/ 2022-11-17T22:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cue_Logo-JvoEQZ.jpeg https://medicaex.com/businesswire/carmell-therapeutics-gains-alignment-with-fda-on-a-path-forward-to-evaluate-the-use-of-its-lead-product-a-bone-healing-accelerant-in-foot-and-ankle-fusion-surgery-2/ 2022-11-17T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/CArmell_Logo-oS1Wj3.jpeg https://medicaex.com/businesswire/carmell-therapeutics-gains-alignment-with-fda-on-a-path-forward-to-evaluate-the-use-of-its-lead-product-a-bone-healing-accelerant-in-foot-and-ankle-fusion-surgery-3/ 2022-11-17T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/CArmell_Logo-Vkdi3d.jpeg https://medicaex.com/businesswire/geron-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/ 2022-11-17T22:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Geron_Full_Logo_RGB-01-FgJ2xG.jpeg https://medicaex.com/businesswire/carmell-therapeutics-gains-alignment-with-fda-on-a-path-forward-to-evaluate-the-use-of-its-lead-product-a-bone-healing-accelerant-in-foot-and-ankle-fusion-surgery/ 2022-11-17T22:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/CArmell_Logo-OEpBrh.jpeg https://medicaex.com/businesswire/cue-health-announces-appointment-of-josh-ghaim-ph-d-and-sachin-jain-m-d-to-its-board-of-directors/ 2022-11-17T22:12:02+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cue_Logo-QgChsq.jpeg https://medicaex.com/businesswire/grail-ccga-discovery-results-published-in-cancer-cell-reveal-methylation-as-promising-dna-hallmark-for-multi-cancer-early-detection-2/ 2022-11-17T21:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Grail_Logo_Velvet_28129-tl5l67.jpeg https://medicaex.com/businesswire/fulgent-genetics-to-participate-in-piper-sandlers-34th-annual-healthcare-conference-3/ 2022-11-17T21:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/FLGT_Logo-g1GRFD.jpeg https://medicaex.com/businesswire/iveric-bio-announces-fda-has-granted-breakthrough-therapy-designation-for-avacincaptad-pegol-for-geographic-atrophy-2/ 2022-11-17T21:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Iveric_Bio_Logo-D8Xoch.jpeg https://medicaex.com/businesswire/fulgent-genetics-to-participate-in-piper-sandlers-34th-annual-healthcare-conference-2/ 2022-11-17T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/FLGT_Logo-ylH8ev.jpeg https://medicaex.com/businesswire/grail-ccga-discovery-results-published-in-cancer-cell-reveal-methylation-as-promising-dna-hallmark-for-multi-cancer-early-detection/ 2022-11-17T21:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Grail_Logo_Velvet_28129-tWU66J.jpeg https://medicaex.com/businesswire/angiodynamics-to-present-at-the-piper-sandler-healthcare-conference-3/ 2022-11-17T21:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/ANGO_-_Logo-Dtiu81.jpeg https://medicaex.com/businesswire/angiodynamics-to-present-at-the-piper-sandler-healthcare-conference-2/ 2022-11-17T21:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/ANGO_-_Logo-MlFqXE.jpeg https://medicaex.com/businesswire/iveric-bio-announces-fda-has-granted-breakthrough-therapy-designation-for-avacincaptad-pegol-for-geographic-atrophy/ 2022-11-17T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Iveric_Bio_Logo-KXtiHQ.jpeg https://medicaex.com/businesswire/fulgent-genetics-to-participate-in-piper-sandlers-34th-annual-healthcare-conference/ 2022-11-17T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/FLGT_Logo-98gU3g.jpeg https://medicaex.com/businesswire/angiodynamics-to-present-at-the-piper-sandler-healthcare-conference/ 2022-11-17T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/ANGO_-_Logo-KVYLCa.jpeg https://medicaex.com/businesswire/the-new-england-journal-of-medicine-and-nejm-group-partner-with-wolters-kluwer-to-expand-global-reach-of-leading-journals-2/ 2022-11-17T19:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Ovid-NEJM-titles-browser-window-ECjP0F.jpeg https://medicaex.com/businesswire/three-ia-employees-honored-with-top-women-in-health-awards/ 2022-11-17T19:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/iA_Logo_High_Res-yLxEZr.jpeg https://medicaex.com/businesswire/the-new-england-journal-of-medicine-and-nejm-group-partner-with-wolters-kluwer-to-expand-global-reach-of-leading-journals/ 2022-11-17T19:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Ovid-NEJM-titles-browser-window-TDAxBm.jpeg https://medicaex.com/businesswire/5-day-biotechnology-for-the-non-biotechnologist-training-course-latest-advances-in-regulations-including-biosimilars-and-advanced-therapies-december-5-9-2022-researchandmarkets-com/ 2022-11-17T18:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-P1ElDL.jpeg https://medicaex.com/businesswire/international-researchers-poised-to-learn-new-insights-about-c2n-diagnostics-blood-test-innovations-at-clinical-trials-on-alzheimers-disease-conference-2/ 2022-11-17T18:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ZZjZdD.jpeg https://medicaex.com/businesswire/immunomet-therapeutics-announces-first-patient-dosed-in-a-phase-1b-trial-of-im156-in-pancreatic-cancer-2/ 2022-11-17T18:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/Immunomet_logo_blue-3gmfm5.jpeg https://medicaex.com/businesswire/hospetrack-hospital-intelligence-for-denmark-a-vision-of-modernizing-hospital-infrastructure-for-a-sustainable-future-researchandmarkets-com/ 2022-11-17T18:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-lJmgkz.jpeg https://medicaex.com/businesswire/gallant-capital-invests-in-lightning-step-to-support-growth/ 2022-11-17T18:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-FPG6Jp.jpeg https://medicaex.com/businesswire/ka-imaging-to-introduce-its-first-mobile-x-ray-unit-at-rsna/ 2022-11-17T18:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Standard-Color-kZj5Dw.jpeg https://medicaex.com/businesswire/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages/ 2022-11-17T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Genexa_Business_Wire_Image_v2-v43ZRL.jpeg https://medicaex.com/businesswire/international-researchers-poised-to-learn-new-insights-about-c2n-diagnostics-blood-test-innovations-at-clinical-trials-on-alzheimers-disease-conference/ 2022-11-17T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-wiu5hP.jpeg https://medicaex.com/businesswire/immunomet-therapeutics-announces-first-patient-dosed-in-a-phase-1b-trial-of-im156-in-pancreatic-cancer/ 2022-11-17T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Immunomet_logo_blue-Bq7b2f.jpeg https://medicaex.com/businesswire/biocodex-group-strengthens-its-position-in-the-us-market-with-the-acquisition-of-hilma-a-fast-growing-natural-remedies-start-up-3/ 2022-11-17T17:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Biocodex_corporate_28129-XJUwFf.jpeg https://medicaex.com/businesswire/smart-biopsy-devices-global-market-report-2022-inclination-towards-minimally-invasive-surgical-procedures-drives-growth-researchandmarkets-com-3/ 2022-11-17T17:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-16O4Fd.jpeg https://medicaex.com/businesswire/gigxr-announces-worldwide-availability-of-insight-series-in-partnership-with-3d-medical-animation-experts-anima-res/ 2022-11-17T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/download-DK0iIA.jpeg https://medicaex.com/businesswire/lsi-announces-first-ever-medtech-ecosystem-partner-in-china/ 2022-11-17T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/LSI_Europe_Recap_w_Watermark-4he0E9.jpeg https://medicaex.com/businesswire/uplyft-signs-10-million-venture-leasing-deal-with-kineo-finance-2/ 2022-11-17T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/UpLyft-Logo-Blue-Background_square-tOrCV9.jpeg https://medicaex.com/businesswire/smart-biopsy-devices-global-market-report-2022-inclination-towards-minimally-invasive-surgical-procedures-drives-growth-researchandmarkets-com-2/ 2022-11-17T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ZIJKsq.jpeg https://medicaex.com/businesswire/biomedevice-silicon-valley-announces-exclusive-master-class-educational-sessions-alongside-highlighted-industry-partners-2/ 2022-11-17T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/P2_926577729_AS_BioMeDevice22_Branding_SilconValleyRedsign_EmailHeaderSample_28129-zevG7T.jpeg https://medicaex.com/businesswire/biomedevice-silicon-valley-announces-exclusive-master-class-educational-sessions-alongside-highlighted-industry-partners/ 2022-11-17T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/P2_926577729_AS_BioMeDevice22_Branding_SilconValleyRedsign_EmailHeaderSample_28129-wYNH6y.jpeg https://medicaex.com/businesswire/uplyft-signs-10-million-venture-leasing-deal-with-kineo-finance/ 2022-11-17T17:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/UpLyft-Logo-Blue-Background_square-1jknXP.jpeg https://medicaex.com/businesswire/smart-biopsy-devices-global-market-report-2022-inclination-towards-minimally-invasive-surgical-procedures-drives-growth-researchandmarkets-com/ 2022-11-17T17:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-QnDm8H.jpeg https://medicaex.com/businesswire/publix-leaders-awarded-as-top-women-in-health-wellness-beauty/ 2022-11-17T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/NewLogoBlack231Choice1-XE59a5.jpeg https://medicaex.com/businesswire/biocodex-group-strengthens-its-position-in-the-us-market-with-the-acquisition-of-hilma-a-fast-growing-natural-remedies-start-up/ 2022-11-17T17:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Biocodex_corporate_28129-OAf4wY.jpeg https://medicaex.com/businesswire/us-hospital-linen-supply-management-services-market-research-report-to-2027-featuring-ameripride-services-angelica-celtic-linen-and-e-town-laundry-among-others-researchandmarkets-com-2/ 2022-11-17T16:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-4VHug2.jpeg https://medicaex.com/businesswire/insitu-biologics-shares-latest-investigational-work-at-asra-meeting-2/ 2022-11-17T16:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/InSitu_Logo_-_Innovative_Solutions_Blue-dINF4k.jpeg https://medicaex.com/businesswire/new-crispr-cas9-agreement-for-ers-genomics-and-atlatl-2/ 2022-11-17T16:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/28179802-2-QYMmws.jpeg https://medicaex.com/businesswire/eso-releases-2022-eso-trauma-index-to-explore-key-trends-and-measures-affecting-trauma-centers-across-the-country/ 2022-11-17T16:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/esoEPS-NXzk3s.jpeg https://medicaex.com/businesswire/saguaro-and-funakoshi-enter-distribution-agreement-to-make-new-non-toxic-dye-technology-available-to-japan/ 2022-11-17T16:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Saguaro_Logo_high_quality_transparent_zoomed-Cqrln2.jpeg https://medicaex.com/businesswire/global-bathroom-and-toilet-assist-devices-market-analysis-report-2022-2030-focus-on-commodes-bath-lifts-bath-aids-shower-chairs-stools-handgrips-grab-bars-toilet-seat-raisers-resea/ 2022-11-17T16:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ImVD3M.jpeg https://medicaex.com/businesswire/global-condom-market-to-grow-by-4-03-billion-during-2022-2026-researchandmarkets-com/ 2022-11-17T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-KGR7zq.jpeg https://medicaex.com/businesswire/us-hospital-linen-supply-management-services-market-research-report-to-2027-featuring-ameripride-services-angelica-celtic-linen-and-e-town-laundry-among-others-researchandmarkets-com/ 2022-11-17T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Q2TJzE.jpeg https://medicaex.com/businesswire/new-crispr-cas9-agreement-for-ers-genomics-and-atlatl/ 2022-11-17T16:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/28179802-2-UkM11P.jpeg https://medicaex.com/businesswire/insitu-biologics-shares-latest-investigational-work-at-asra-meeting/ 2022-11-17T16:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/InSitu_Logo_-_Innovative_Solutions_Blue-WfPPMH.jpeg https://medicaex.com/businesswire/mindcare-partners-with-thinkandor-to-provide-ai-enabled-virtual-care-to-combat-nationwide-mental-health-crisis/ 2022-11-17T16:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/mindcare_logo-xyqjDY.jpeg https://medicaex.com/businesswire/feinstein-institutes-lupus-researchers-recognized-with-top-honors-2/ 2022-11-17T15:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Diamond_Davidson_1_copy-Le5Ckl.jpeg https://medicaex.com/businesswire/escient-pharmaceuticals-initiates-phase-2-pacific-study-evaluating-ep547-an-oral-mrgprx4-antagonist-in-subjects-with-cholestatic-pruritus-2/ 2022-11-17T15:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Escient_Logo_28white_background29-HvsDin.jpeg https://medicaex.com/businesswire/scribe-therapeutics-to-participate-in-four-upcoming-conferences-2/ 2022-11-17T15:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Scribe_Logo-kswZd1.jpeg https://medicaex.com/businesswire/alveo-technologies-announces-new-executive-leadership-open-platform-strategy-3/ 2022-11-17T15:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Alveo_Technologies2C_Inc-r8jSVF.jpeg https://medicaex.com/businesswire/dentalcorp-announces-presentations-at-upcoming-investor-conferences/ 2022-11-17T15:12:14+00:00 https://medicaex.com/businesswire/alveo-technologies-announces-new-executive-leadership-open-platform-strategy-2/ 2022-11-17T15:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Alveo_Technologies2C_Inc-s2SQHE.jpeg https://medicaex.com/businesswire/cleerly-partners-with-heartbeat-health-in-new-heart-disease-detection-program/ 2022-11-17T15:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cleerly_Logo-TMdEcc.jpeg https://medicaex.com/businesswire/biofuture-conference-brings-together-stakeholders-in-transformative-healthcare-summit-2/ 2022-11-17T15:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/biofuture_logo-e1nW1P.jpeg https://medicaex.com/businesswire/k-health-platform-now-addressing-weight-loss-to-help-prevent-and-manage-multiple-chronic-conditions-3/ 2022-11-17T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/k-health-dark-blue-JRbkrz.jpeg https://medicaex.com/businesswire/risas-dental-and-braces-taps-pearl-to-bring-ai-enhanced-dental-care-to-patients-across-southwestern-us-2/ 2022-11-17T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Pearl_logo-lALl1u.jpeg https://medicaex.com/businesswire/understanding-the-link-between-nafld-and-diabetes-echosens-points-to-new-aace-guideline-supporting-fibroscan-as-key-component-of-type-2-diabetes-management/ 2022-11-17T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_echosens_gradient-tmhfU3.jpeg https://medicaex.com/businesswire/namsa-transforms-integrated-medtech-commercialization-solution-the-namsa-apex-program/ 2022-11-17T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/APEX_program-graphic_with_NAMSA_logo-IXr1xy.jpeg https://medicaex.com/businesswire/risas-dental-and-braces-taps-pearl-to-bring-ai-enhanced-dental-care-to-patients-across-southwestern-us/ 2022-11-17T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Pearl_logo-uVgiTh.jpeg https://medicaex.com/businesswire/alveo-technologies-announces-new-executive-leadership-open-platform-strategy/ 2022-11-17T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Alveo_Technologies2C_Inc-f5Hgtf.jpeg https://medicaex.com/businesswire/heru-wins-prestigious-ces-innovation-award-for-2nd-consecutive-year-with-expanded-multimodal-platform/ 2022-11-17T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Heru_Logo-YsAZXh.jpeg https://medicaex.com/businesswire/global-injectable-drug-delivery-devices-market-2022-2026-digitalization-of-healthcare-sector-driving-growth-researchandmarkets-com/ 2022-11-17T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-RgsXFY.jpeg https://medicaex.com/businesswire/feinstein-institutes-lupus-researchers-recognized-with-top-honors/ 2022-11-17T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Diamond_Davidson_1_copy-9F9WAs.jpeg https://medicaex.com/businesswire/escient-pharmaceuticals-initiates-phase-2-pacific-study-evaluating-ep547-an-oral-mrgprx4-antagonist-in-subjects-with-cholestatic-pruritus/ 2022-11-17T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Escient_Logo_28white_background29-GQ9VoU.jpeg https://medicaex.com/businesswire/scribe-therapeutics-to-participate-in-four-upcoming-conferences/ 2022-11-17T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Scribe_Logo-oqJCTP.jpeg https://medicaex.com/businesswire/k-health-platform-now-addressing-weight-loss-to-help-prevent-and-manage-multiple-chronic-conditions-2/ 2022-11-17T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/k-health-dark-blue-djM9GG.jpeg https://medicaex.com/businesswire/k-health-platform-now-addressing-weight-loss-to-help-prevent-and-manage-multiple-chronic-conditions/ 2022-11-17T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/k-health-dark-blue-t4tmls.jpeg https://medicaex.com/businesswire/biofuture-conference-brings-together-stakeholders-in-transformative-healthcare-summit/ 2022-11-17T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/biofuture_logo-GIx6W0.jpeg https://medicaex.com/businesswire/livanova-receives-510k-clearance-for-ecmo-from-fda-for-lifesparc-the-next-generation-advanced-circulatory-support-system-2/ 2022-11-17T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/LN-Logo-Main-PANTONE-7OtmrK.jpeg https://medicaex.com/businesswire/study-reveals-florence-healthcares-site-enablement-platforms-can-accelerate-clinical-trials-by-six-weeks-and-reduce-costs-by-over-1m-per-study-3/ 2022-11-17T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/FHC_Logo_2800229-pc1M46.jpeg https://medicaex.com/businesswire/beren-awarded-expedited-roadmap-for-treatment-of-homozygous-familial-hypercholesterolemia-2/ 2022-11-17T14:12:13+00:00 https://medicaex.com/businesswire/immunitybio-to-participate-in-34th-annual-piper-sandler-healthcare-conference-2/ 2022-11-17T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/BusinessWire_-ImmunityBio-rYCDMz.jpeg https://medicaex.com/businesswire/ladrx-corporation-issues-corporate-update-for-3q22-2/ 2022-11-17T14:12:13+00:00 https://medicaex.com/businesswire/study-reveals-florence-healthcares-site-enablement-platforms-can-accelerate-clinical-trials-by-six-weeks-and-reduce-costs-by-over-1m-per-study-2/ 2022-11-17T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/FHC_Logo_2800229-zuSN13.jpeg https://medicaex.com/businesswire/livanova-receives-510k-clearance-for-ecmo-from-fda-for-lifesparc-the-next-generation-advanced-circulatory-support-system/ 2022-11-17T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/LN-Logo-Main-PANTONE-hUVsFi.jpeg https://medicaex.com/businesswire/vietnam-ultrasound-systems-diagnostic-v-s-therapeutic-markets-analysis-competition-forecasts-opportunities-2017-2022-2023-2027-researchandmarkets-com/ 2022-11-17T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-rrR9MQ.jpeg https://medicaex.com/businesswire/surmodics-announces-12-month-data-from-the-swing-trial-presented-at-veithsymposium-2/ 2022-11-17T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/press_release_logo-RXZmhi.jpeg https://medicaex.com/businesswire/neuraptive-therapeutics-inc-announces-appointment-of-leading-industry-executive-dr-robert-r-ruffolo-as-new-director-to-the-board/ 2022-11-17T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/RR_Picture-JlU3Nm.jpeg https://medicaex.com/businesswire/surmodics-announces-12-month-data-from-the-swing-trial-presented-at-veithsymposium/ 2022-11-17T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/press_release_logo-f5Bo4l.jpeg https://medicaex.com/businesswire/beren-awarded-expedited-roadmap-for-treatment-of-homozygous-familial-hypercholesterolemia/ 2022-11-17T14:12:05+00:00 https://medicaex.com/businesswire/immunitybio-to-participate-in-34th-annual-piper-sandler-healthcare-conference/ 2022-11-17T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/BusinessWire_-ImmunityBio-fUjIg7.jpeg https://medicaex.com/businesswire/ladrx-corporation-issues-corporate-update-for-3q22/ 2022-11-17T14:12:05+00:00 https://medicaex.com/businesswire/quillibrium-wins-crop-science-award-for-best-new-biological-product-biopesticide/ 2022-11-17T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Crop_Science_Award_photo_28L_-_R29_CEO_Gaston_Salinas_-_BSI2C_Corey_Huck2C_Syngenta_Head_Global_Business2C_Diego_Ibanez2C_SVP_BSI2C_Laszlo_Laczko_Syngenta_Head_Global_Bus_Development-3Juc4h.jpeg https://medicaex.com/businesswire/study-reveals-florence-healthcares-site-enablement-platforms-can-accelerate-clinical-trials-by-six-weeks-and-reduce-costs-by-over-1m-per-study/ 2022-11-17T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/FHC_Logo_2800229-wSZXjY.jpeg https://medicaex.com/businesswire/antidote-health-launches-telemedicine-service-for-prediabetes-and-type-2-diabetes/ 2022-11-17T14:12:03+00:00 https://medicaex.com/businesswire/btig-to-host-digital-health-forum-on-november-21-2022/ 2022-11-17T14:12:03+00:00 https://medicaex.com/businesswire/novocure-announces-25-abstracts-on-tumor-treating-fields-therapy-at-society-for-neuro-oncology-2022-annual-meeting-2/ 2022-11-17T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/novocure_main405x-YSyOgt.jpeg https://medicaex.com/businesswire/federal-court-rules-for-masimo-in-suit-against-former-engineer-for-unlawful-theft-of-companys-pulse-oximeter-trade-secrets-2/ 2022-11-17T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Masimo_logo_black_flat_nomark-MwZVVb.jpeg https://medicaex.com/businesswire/alloy-therapeutics-and-normunity-sign-multi-program-antibody-discovery-collaboration-in-immuno-oncology/ 2022-11-17T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Alloy_Therapeutics_logo_black_RGB-HI7uld.jpeg https://medicaex.com/businesswire/incyte-to-present-at-upcoming-investor-conferences-2/ 2022-11-17T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Incyte_Color_Logo_JPEG_282_Color_Positive29-eyCgZs.jpeg https://medicaex.com/businesswire/grant-avenue-capital-launches-helios-clinical-research-2/ 2022-11-17T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Grant_Avenue_Logo-TkR9A0.jpeg https://medicaex.com/businesswire/universal-dx-presents-methylation-biomarker-data-at-aacr-special-conference-precision-prevention-early-detection-and-interception-of-cancer/ 2022-11-17T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-abqbUw.jpeg https://medicaex.com/businesswire/federal-court-rules-for-masimo-in-suit-against-former-engineer-for-unlawful-theft-of-companys-pulse-oximeter-trade-secrets/ 2022-11-17T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Masimo_logo_black_flat_nomark-Rm9g4S.jpeg https://medicaex.com/businesswire/ge-healthcare-announces-80-million-investment-to-expand-contrast-media-production-capacity-2/ 2022-11-17T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/GE_Healthcare_Manufacturing_Facility2C_Lindesnes2C_Norway-Wl8pKN.jpeg https://medicaex.com/businesswire/theragun-black-friday-deals-2022-early-theragun-prime-elite-pro-mini-more-savings-rounded-up-by-deal-tomato-2/ 2022-11-17T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Black_Friday_Logo_4-Z80KmB.jpeg https://medicaex.com/businesswire/ge-healthcare-announces-80-million-investment-to-expand-contrast-media-production-capacity/ 2022-11-17T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/GE_Healthcare_Manufacturing_Facility2C_Lindesnes2C_Norway-uuMjfJ.jpeg https://medicaex.com/businesswire/theragun-black-friday-deals-2022-early-theragun-prime-elite-pro-mini-more-savings-rounded-up-by-deal-tomato/ 2022-11-17T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Black_Friday_Logo_4-wWYXcD.jpeg https://medicaex.com/businesswire/organigram-and-intercure-dba-canndoc-sign-new-international-strategic-agreement-representing-largest-such-deal-to-date-for-both-companies/ 2022-11-17T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/OGI_LogoHorizontalCMYK-h7zfQe.jpeg https://medicaex.com/businesswire/incyte-to-present-at-upcoming-investor-conferences/ 2022-11-17T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Incyte_Color_Logo_JPEG_282_Color_Positive29-3f04W5.jpeg https://medicaex.com/businesswire/grant-avenue-capital-launches-helios-clinical-research/ 2022-11-17T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Grant_Avenue_Logo-3agT8P.jpeg https://medicaex.com/businesswire/novocure-announces-25-abstracts-on-tumor-treating-fields-therapy-at-society-for-neuro-oncology-2022-annual-meeting/ 2022-11-17T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/novocure_main405x-tt14mY.jpeg https://medicaex.com/businesswire/afrin-wows-parents-with-launch-of-childrens-acute-medicated-nasal-sprays-because-one-sick-kid-can-throw-everything-off-in-an-instant/ 2022-11-17T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bayer_Logo-dsPjtf.jpeg https://medicaex.com/businesswire/research-published-in-melanoma-management-finds-that-99-of-patients-with-uveal-melanoma-tested-with-decisiondx-um-gain-value-from-the-results-2/ 2022-11-17T12:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/CastleLogo2Color-nm0Y7L.jpeg https://medicaex.com/businesswire/puretech-to-present-at-two-upcoming-investor-conferences-2/ 2022-11-17T12:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Piper_and_Evercore_FINAL-3gEeHt.jpeg https://medicaex.com/businesswire/mammoth-biosciences-named-to-fast-companys-2022-list-of-the-next-big-things-in-tech-2/ 2022-11-17T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Mammoth_Logo-XbEOFX.jpeg https://medicaex.com/businesswire/cardio-diagnostics-named-to-fast-companys-second-annual-list-of-the-next-big-things-in-tech/ 2022-11-17T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cardio_Diagnostics_Logo_1-BaJrUK.jpeg https://medicaex.com/businesswire/marinus-pharmaceuticals-announces-collaboration-with-tenacia-biotechnology-for-ganaxolone-development-and-commercialization-in-china-2/ 2022-11-17T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/marinus-color-j2Zfvy.jpeg https://medicaex.com/businesswire/levels-named-to-fast-companys-second-annual-list-of-the-next-big-things-in-tech-2/ 2022-11-17T12:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/LEVELS_Logo_Primary_2Color_Dark-diwfiw.jpeg https://medicaex.com/businesswire/levels-named-to-fast-companys-second-annual-list-of-the-next-big-things-in-tech/ 2022-11-17T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/LEVELS_Logo_Primary_2Color_Dark-otLG30.jpeg https://medicaex.com/businesswire/staar-surgical-opens-evo-experience-center-in-united-states-2/ 2022-11-17T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/PHOTO_1-pKKFme.jpeg https://medicaex.com/businesswire/global-medical-tubing-market-report-2022-increasing-demand-for-minimally-invasive-procedures-drives-growth-researchandmarkets-com/ 2022-11-17T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-NZrlnw.jpeg https://medicaex.com/businesswire/henry-schein-cares-foundation-and-the-american-association-of-dental-office-management-present-the-ninth-annual-green-leader-award-to-ocean-dentals-jennifer-z-vickery/ 2022-11-17T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/HenrySchein_2000x374-m0wl5T.jpeg https://medicaex.com/businesswire/staar-surgical-opens-evo-experience-center-in-united-states/ 2022-11-17T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/PHOTO_1-3dF8iF.jpeg https://medicaex.com/businesswire/marinus-pharmaceuticals-announces-collaboration-with-tenacia-biotechnology-for-ganaxolone-development-and-commercialization-in-china/ 2022-11-17T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/marinus-color-L8lOEG.jpeg https://medicaex.com/businesswire/research-published-in-melanoma-management-finds-that-99-of-patients-with-uveal-melanoma-tested-with-decisiondx-um-gain-value-from-the-results/ 2022-11-17T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/CastleLogo2Color-uwsmnn.jpeg https://medicaex.com/businesswire/puretech-to-present-at-two-upcoming-investor-conferences/ 2022-11-17T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Piper_and_Evercore_FINAL-sjy8nk.jpeg https://medicaex.com/businesswire/marinus-pharmaceuticals-appoints-ceo-scott-braunstein-m-d-as-chairman-of-the-board/ 2022-11-17T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Marinus_logo-GN8NfU.jpeg https://medicaex.com/businesswire/mammoth-biosciences-named-to-fast-companys-2022-list-of-the-next-big-things-in-tech/ 2022-11-17T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Mammoth_Logo-rE0AWe.jpeg https://medicaex.com/businesswire/vizient-announces-strategic-partnership-with-handle-global-to-launch-capital-asset-management-system/ 2022-11-17T11:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Vizient_Logo_V2-LDM8kp.jpeg https://medicaex.com/businesswire/the-worldwide-hemophilia-treatment-industry-is-projected-to-reach-26-9-billion-by-2031-researchandmarkets-com/ 2022-11-17T11:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-dqfysB.jpeg https://medicaex.com/businesswire/global-collagen-market-report-2022-rising-demand-for-collagen-in-the-food-beverage-and-pharmaceutical-industries-to-drive-growth-researchandmarkets-com/ 2022-11-17T11:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-RqNgRU.jpeg https://medicaex.com/businesswire/aster_wise-solution-to-serve-the-smart-community-in-indonesia/ 2022-11-17T11:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Aster-EkyGsj.jpeg https://medicaex.com/businesswire/global-asthma-warning-sensors-wearable-v-s-non-wearable-markets-competition-forecast-and-opportunities-2017-2021-2022-2027-researchandmarkets-com/ 2022-11-17T10:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-1oPOfh.jpeg https://medicaex.com/businesswire/breast-pumps-global-markets-report-2022-with-profiles-of-major-players-medela-pigeon-spectra-baby-usa-koninklijke-philips-and-ameda-researchandmarkets-com/ 2022-11-17T10:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-3sfsjG.jpeg https://medicaex.com/businesswire/outlook-on-the-endoluminal-suturing-devices-global-market-to-2028-featuring-apollo-endosurgery-medtronic-cook-medical-and-suture-among-others-researchandmarkets-com/ 2022-11-17T10:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Zcmb7L.jpeg https://medicaex.com/businesswire/biodesix-announces-pricing-of-35-1-million-upsized-public-offering-of-common-stock/ 2022-11-17T06:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Biodesix_Logo-6mtLrN.jpeg